Two Sigma Investments’s Matinas BioPharma MTNB Stock Holding History

Two Sigma Investments’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-525	Closed	-$20K	–	4535
2021 Q2	$20K	Buy	+525	New	+$22.6K	﹤0.01%	3956
2021 Q1	–	Sell	-1,915	Closed	-$130K	–	4107
2020 Q4	$130K	Sell	1,915 -27,466	-93%	-$1.27M	﹤0.01%	3181
2020 Q3	$1.13M	Buy	29,381 +3,731	+15%	+$148K	﹤0.01%	1674
2020 Q2	$991K	Buy	25,650 +12,185	+90%	+$467K	﹤0.01%	1541
2020 Q1	$404K	Buy	+13,465	New	+$813K	﹤0.01%	2085
2019 Q4	–	Sell	-225	Closed	-$7K	–	3870
2019 Q3	$7K	Buy	+225	New	+$8.13K	﹤0.01%	3390

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

AWA

Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's MTNB Position: Q3 2021 in Review

Two Sigma Investments sold out of Matinas BioPharma (MTNB) in Q3 2021, closing a stake of 525 shares — an estimated $20K sold.

Two Sigma Investments first reported a position in MTNB in Q3 2019 and held it in 6 quarters. The position peaked at $1.13M in Q3 2020. 67 funds tracked by Wall St. Rank hold MTNB as of Q3 2021.

Two Sigma Investments reported no remaining Matinas BioPharma position as of Q3 2021 after selling out during the quarter.
Two Sigma Investments sold 525 Matinas BioPharma shares in Q3 2021, an estimated $20K.
Two Sigma Investments first reported a position in Matinas BioPharma in Q3 2019 and held it in 6 quarters.
Two Sigma Investments's Matinas BioPharma position peaked at $1.13M in Q3 2020.
67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.